Handgrip strength was significantly associated with improved visual memory reaction time, prospective memory, and reasoning in patients with bipolar disorder.
Lundbeck announced that the FDA has approved a sNDA for Trintellix to include data regarding improved processing speed.
A team of investigators assessed the effect of intravenous administration of methylprednisolone on duration of episodes in adolescent and young adult patients with Kleine-Levin syndrome.
Levels of magnesium, folate, vitamin B12, zinc, and vitamin D 25-OH were significantly altered in children with ADHD.
Although compensating for their difficulties may help people with ASD connect with others, get jobs, and successfully navigate social situations, accumulating research suggests it can also lead to exhaustion, burnout, anxiety, and depression.
Co-occurrence of ADHD is common in children with autism spectrum disorder.
Reductions in bilateral frontal, parietal, and temporal lobe gray matter volumes found in ADHD.
For patients with major depressive disorde, relapse is associated with brain cortical changes over two years.
Adolescent females at high familial risk of depression who do not go on to develop depression have compensatory functional connectivity patterns in emotion regulatory networks.
Severe pediatric traumatic brain injury increases secondary ADHD risk.
Use of HIRREM, a closed-loop, allostatic, acoustic, stimulation neurotechnology can reduce PTSD symptoms, insomnia and depression in veterans.
For adults with bipolar depression, tDCS seems to be safe and effective as an add-on intervention.
Depression is one of the most commonly reported complications resulting from stroke.
Paternal use of SSRIs before conception is linked to an increased risk of ADHD in offspring.
No overall difference in terms of total brain volume or total gray and white matter volume for children with ADHD and control subjects was observed.
Nonoptimal infant neuromotor development was linked to genetic risk for schizophrenia, but not bipolar disorder.
Brexanolone was well tolerated among study participants.
There is an increased relative risk of preclampsia linked with psychostimulant use while pregnant.
Frequency of migraine with or without aura may be correlated with symptoms of anxiety and depression.
The FDA has cleared Nexstim's NBT system for the treatment of major depressive disorder.
There is an increased risk of neonatal morbidity associated with exposure to ADHD medication in utero.
Specific inflammatory biomarkers may have an impact on the risk of developing schizophrenia.
For patients with comorbid depression and TBI, NILT is effective in bringing remission.
Given the prevalence of depression in Parkinson's disease and the effectiveness of antidepressants, health care providers should promote adherence in clinical practice.
Incidence of neuroleptic malignant syndrome, akathisia, and parkinsonism was higher in the ID group.
A panel of clinicians from different pediatric fields have developed new guidelines for the treatment of PANS.
Youth who have bipolar disorder are not affected by a decline in cognitive function into adulthood.
The findings suggest the importance of screening for posttraumatic stress disorder in this population.
Previous research has found a higher prevalence of depression before and after an epilepsy diagnosis.
Escitalopram may be better for the treatment of depression than tDCS.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics